在患有2型喘,血中中微粒细胞升高或不升高的患者中杜皮卢马布的有效性
Eugene R Bleecker1, Reynold A Panettieri2, Njira L Lugogo3
1University of Arizona, College of Medicine, Division of Genomics and Precision Medicine, Department of Medicine, 1230 North Cherry Street, Suite 251, Tucson, AZ 85721, USA.
Journal of immunology research
|October 30, 2023
概括
杜皮卢马布有效地减少了严重的喘恶化,并改善了2型喘患者的肺功能,无论他们的血液中性粒细胞数量如何. 这一发现支持dupilumab作为不受控制的中度至重度喘的治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 升高的中性粒细胞计数与2型喘的较差结果有关.
- 在LIBERTY ASTHMA QUEST试验中,dupilumab在中度至重度喘中表现出有效性.
研究的目的:
- 为了评估dupilumab在2型喘患者的有效性,在2型喘患者的血中中微粒细胞数量基本值有所变化.
- 根据中性粒细胞水平分析恶化率和肺功能变化.
主要方法:
- 我们对QUEST试验 (NCT02414854) 进行了后期分析.
- 患有2型生物标志物升高的患者通过低 (<4,000细胞/μL) 或高 (≥4,000细胞/μL) 中性粒细胞计数进行了分层.
- 在52周内评估了每年严重恶化率和1秒内强制呼气体积 (FEV1) 变化.
主要成果:
- 在所有中性粒细胞计数组中,杜皮卢马布显著减少了严重喘恶化与安慰剂相比 (P < 0.0001).
- 从第二周开始,与安慰剂相比,在dupilumab治疗中观察到显著的FEV1改善,无论中性粒细胞水平如何 (P < 0.001).
- 无论基线中性粒细胞数量如何,安全性概况在各个子组中都是一致的.
结论:
- 杜皮卢马布在减轻恶化和改善中度至重度2型喘的肺功能方面表现出显著的有效性.
- 杜皮卢马布的治疗益处独立于基线血中微粒细胞计数.
- 杜皮卢马布是2型喘患者的可行的治疗选择,无论中性粒细胞水平如何.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
01:19Antiasthma Drugs: Leukotriene Modifiers
324
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
324
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
278
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
278
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421